InvestorsHub Logo
Followers 46
Posts 4581
Boards Moderated 0
Alias Born 07/26/2010

Re: XenaLives post# 356

Wednesday, 12/02/2020 9:26:41 AM

Wednesday, December 02, 2020 9:26:41 AM

Post# of 397
VNDA 12.34 - FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome

https://ih.advfn.com/stock-market/NASDAQ/vanda-pharmaceuticals-VNDA/stock-news/83807075/fda-approves-hetlioz-tasimelteon-for-the-treatmen
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VNDA News